Asthma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged between 18 and 65 years
- People who have been diagnosed with severe, persistent, non-allergic asthma by a lung specialist, following recognised international asthma guidelines
- People whose asthma test results show certain inflammation markers — specifically, low levels of a blood cell type called eosinophils (below 150/µL), and/or a negative skin allergy test, and/or low levels of a protein called IgE (below 30 kU/L)
- People whose lungs show a meaningful improvement in airflow (at least 12% or 200mL) after using a reliever inhaler during breathing tests
- People who received their asthma diagnosis at least 6 months ago and have been receiving ongoing follow-up and treatment, and/or whose asthma is currently under control
Who may not be able to join:
- People who have had a respiratory (chest or airway) infection within the past month
- People with a significant smoking history (more than 10 pack-years), or who have smoked within the past 6 months
- People who have taken steroid tablets or liquid steroids (oral corticosteroids) in the past 4 weeks
- People with a Body Mass Index (BMI) above 35
- People who have been diagnosed with certain specific lung or blood vessel conditions, including Eosinophilic Granulomatosis with Polyangiitis (EGPA), Allergic Bronchopulmonary Aspergillosis (ABPA), or vasculitis (confirm with trial site)
- People with a history of cancer
- People who are pregnant
- People who have previously had lung surgery, or who currently use long-term oxygen therapy
- People who have certain conditions affecting the spine, joints, or muscles that would prevent reliable breathing test results or participation in rehabilitation (such as severe spinal curvature, ankylosing spondylitis, myasthenia gravis, or muscular dystrophies/myopathies)
- People who have conditions affecting thinking, understanding, or memory — such as cognitive dysfunction, intellectual disability, or dementia — that could make it difficult to follow the study procedures or for results to be accurately interpreted
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +90 216 777 8 777
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Maximal inspiratory pressure (MIP) measurement; Six minute walking test; Modified Medical Research Council (mMRC) Dyspnea Scale
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.